Caliway Biopharmaceuticals Co., Ltd. (TPEX: 6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
541.00
-14.00 (-2.52%)
Sep 10, 2024, 2:59 PM CST

Caliway Biopharmaceuticals Market Cap

Caliway Biopharmaceuticals has a market cap or net worth of 75.43 billion as of September 10, 2024. Its market cap has increased by 243.72% in one year.

Market Cap
75.43B
Enterprise Value
72.10B
Revenue
35.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
541.00

Market Cap Chart

Since December 26, 2022, Caliway Biopharmaceuticals's market cap has increased from 7.96B to 75.43B, an increase of 847.75%. That is a compound annual growth rate of 272.65%.

History

DateMarket Cap% Change
Sep 10, 202475.43B183.56%
Dec 29, 202326.60B253.33%
Dec 30, 20227.53B-5.41%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition